Artykuły w czasopismach na temat „Myelin protein zero”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Myelin protein zero”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Choe, Senyon. "Packing of Myelin Protein Zero." Neuron 17, no. 3 (1996): 363–65. http://dx.doi.org/10.1016/s0896-6273(00)80167-1.
Pełny tekst źródłaRaasakka, Arne, and Petri Kursula. "How Does Protein Zero Assemble Compact Myelin?" Cells 9, no. 8 (2020): 1832. http://dx.doi.org/10.3390/cells9081832.
Pełny tekst źródłaSpiryda, Lisa. "Myelin protein zero and membrane adhesion." Journal of Neuroscience Research 54, no. 2 (1998): 137–46. http://dx.doi.org/10.1002/(sici)1097-4547(19981015)54:2<137::aid-jnr2>3.0.co;2-f.
Pełny tekst źródłaRaasakka, Arne, Oda C. Krokengen, Robert Schneider, and Petri Kursula. "Myelin protein zero - the structural foundation behind peripheral compact myelin." Biophysical Journal 122, no. 3 (2023): 500a. http://dx.doi.org/10.1016/j.bpj.2022.11.2669.
Pełny tekst źródłaFernandez-Valle, C., N. Fregien, P. M. Wood, and M. B. Bunge. "Expression of the protein zero myelin gene in axon-related Schwann cells is linked to basal lamina formation." Development 119, no. 3 (1993): 867–80. http://dx.doi.org/10.1242/dev.119.3.867.
Pełny tekst źródłaWarner, Laura E., Benjamin B. Roa, and James R. Lupski. "Settling the myelin protein zero question in CMT1B." Nature Genetics 11, no. 2 (1995): 119–20. http://dx.doi.org/10.1038/ng1095-119.
Pełny tekst źródłaD’Urso, Donatella, Peter Ehrhardt, and Hans Werner Müller. "Peripheral Myelin Protein 22 and Protein Zero: a Novel Association in Peripheral Nervous System Myelin." Journal of Neuroscience 19, no. 9 (1999): 3396–403. http://dx.doi.org/10.1523/jneurosci.19-09-03396.1999.
Pełny tekst źródłaGould, Robert M., Todd Oakley, Jared V. Goldstone, Jason C. Dugas, Scott T. Brady, and Alexander Gow. "Myelin sheaths are formed with proteins that originated in vertebrate lineages." Neuron Glia Biology 4, no. 2 (2008): 137–52. http://dx.doi.org/10.1017/s1740925x09990238.
Pełny tekst źródłaPeirano, Reto I., Derk E. Goerich, Dieter Riethmacher, and Michael Wegner. "Protein Zero Gene Expression Is Regulated by the Glial Transcription Factor Sox10." Molecular and Cellular Biology 20, no. 9 (2000): 3198–209. http://dx.doi.org/10.1128/mcb.20.9.3198-3209.2000.
Pełny tekst źródłaGeorgiou, John, and Milton P. Charlton. "Non-myelin-forming perisynaptic Schwann cells express protein zero and myelin-associated glycoprotein." Glia 27, no. 2 (1999): 101–9. http://dx.doi.org/10.1002/(sici)1098-1136(199908)27:2<101::aid-glia1>3.0.co;2-h.
Pełny tekst źródłaSouayah, Nizar, and Peter Siao Tick Chong. "Asymmetric Phenotype Associated With Rare Myelin Protein Zero Mutation." Journal of Clinical Neuromuscular Disease 11, no. 3 (2010): 110–13. http://dx.doi.org/10.1097/cnd.0b013e3181c5058a.
Pełny tekst źródłaMandich, P., G. L. Mancardi, A. Varese, et al. "Congenital hypomyelination due to myelin protein zero Q215X mutation." Annals of Neurology 45, no. 5 (1999): 676–78. http://dx.doi.org/10.1002/1531-8249(199905)45:5<676::aid-ana21>3.0.co;2-k.
Pełny tekst źródłaHasse, Birgit, Frank Bosse, Helmut Hanenberg, and Hans Werner Müller. "Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions." Molecular and Cellular Neuroscience 27, no. 4 (2004): 370–78. http://dx.doi.org/10.1016/j.mcn.2004.06.009.
Pełny tekst źródłaPlotkowski, Megan L., Sanguk Kim, Martin L. Phillips, Anthony W. Partridge, Charles M. Deber, and James U. Bowie. "Transmembrane Domain of Myelin Protein Zero Can Form Dimers: Possible Implications for Myelin Construction†." Biochemistry 46, no. 43 (2007): 12164–73. http://dx.doi.org/10.1021/bi701066h.
Pełny tekst źródłaMurad, Abbas Mahmood, Maysaa Jalal Majeed, Rafid Badri Al-Ameri, and Ahmed Salim AL-Haidari. "Serum Myelin Oligodendrocyte Glycoprotein and Myelin Protein Zero as Diagnostic Biomarkers in Diabetic Neuropathy." AL-Kindy College Medical Journal 19, no. 1 (2023): 42–47. http://dx.doi.org/10.47723/kcmj.v19i1.859.
Pełny tekst źródłaKim, Hye-Jung, Cha-Gyun Jung, Mark A. Jensen, Danuta Dukala, and Betty Soliven. "Targeting of Myelin Protein Zero in a Spontaneous Autoimmune Polyneuropathy." Journal of Immunology 181, no. 12 (2008): 8753–60. http://dx.doi.org/10.4049/jimmunol.181.12.8753.
Pełny tekst źródłaSago, Haruhiko, Ying Su, and Roger Lebo. "Reply to “Settling the myelin protein zero question in CMT1B”." Nature Genetics 11, no. 2 (1995): 120. http://dx.doi.org/10.1038/ng1095-120.
Pełny tekst źródłaShy, Michael E. "Peripheral neuropathies caused by mutations in the myelin protein zero." Journal of the Neurological Sciences 242, no. 1-2 (2006): 55–66. http://dx.doi.org/10.1016/j.jns.2005.11.015.
Pełny tekst źródłaSouayah, Nizar, W. K. Seltzer, Thomas H. Brannagan, Russell L. Chin, and Howard W. Sander. "Rare myelin protein zero sequence variant in late onset CMT1B." Journal of the Neurological Sciences 263, no. 1-2 (2007): 177–79. http://dx.doi.org/10.1016/j.jns.2007.05.020.
Pełny tekst źródłaSouayah, N., and P. Siao Tick Chong. "58. Asymmetric phenotype associated with rare Myelin protein zero mutation." Clinical Neurophysiology 120, no. 2 (2009): e105. http://dx.doi.org/10.1016/j.clinph.2008.10.076.
Pełny tekst źródłaBrösamle, Christian. "The myelin proteolipid DMalpha in fishes." Neuron Glia Biology 6, no. 2 (2009): 109–12. http://dx.doi.org/10.1017/s1740925x09000131.
Pełny tekst źródłaLuo, XiaoYang, Deepak Sharma, Hideyo Inouye та ін. "Cytoplasmic Domain of Human Myelin Protein Zero Likely Folded as β-Structure in Compact Myelin". Biophysical Journal 92, № 5 (2007): 1585–97. http://dx.doi.org/10.1529/biophysj.106.094722.
Pełny tekst źródłaSmirnova, Evgeniya V., Tatiana V. Rakitina, Rustam H. Ziganshin, et al. "Identification of Myelin Basic Protein Proximity Interactome Using TurboID Labeling Proteomics." Cells 12, no. 6 (2023): 944. http://dx.doi.org/10.3390/cells12060944.
Pełny tekst źródłaRaasakka, Arne, Nykola C. Jones, Søren Vrønning Hoffmann, and Petri Kursula. "Ionic strength and calcium regulate membrane interactions of myelin basic protein and the cytoplasmic domain of myelin protein zero." Biochemical and Biophysical Research Communications 511, no. 1 (2019): 7–12. http://dx.doi.org/10.1016/j.bbrc.2019.02.025.
Pełny tekst źródłaFratta, Pietro, Francesca Ornaghi, Gabriele Dati, et al. "A nonsense mutation in myelin protein zero causes congenital hypomyelination neuropathy through altered P0 membrane targeting and gain of abnormal function." Human Molecular Genetics 28, no. 1 (2018): 124–32. http://dx.doi.org/10.1093/hmg/ddy336.
Pełny tekst źródłaLeBlanc, Scott E., Rebecca M. Ward, and John Svaren. "Neuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10." Molecular and Cellular Biology 27, no. 9 (2007): 3521–29. http://dx.doi.org/10.1128/mcb.01689-06.
Pełny tekst źródłaWatanabe, M., N. Yamamoto, N. Ohkoshi, et al. "Corticosteroid- responsive asymmetric neuropathy with a myelin protein zero gene mutation." Neurology 59, no. 5 (2002): 767–69. http://dx.doi.org/10.1212/wnl.59.5.767.
Pełny tekst źródłaLeBlanc, Scott E., Sung-Wook Jang, Rebecca M. Ward, Lawrence Wrabetz, and John Svaren. "Direct Regulation of Myelin Protein Zero Expression by the Egr2 Transactivator." Journal of Biological Chemistry 281, no. 9 (2005): 5453–60. http://dx.doi.org/10.1074/jbc.m512159200.
Pełny tekst źródłaMarchini, Corrado, Sandro Zambito Marsala, Matteo Bendini, et al. "Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy." Neuromuscular Disorders 19, no. 12 (2009): 849–52. http://dx.doi.org/10.1016/j.nmd.2009.09.004.
Pełny tekst źródłaLemke, Greg, Elise Lamar, and John Patterson. "Isolation and analysis of the gene encoding peripheral myelin protein zero." Neuron 1, no. 1 (1988): 73–83. http://dx.doi.org/10.1016/0896-6273(88)90211-5.
Pełny tekst źródłaLatour, P., C. Bonnebouche, M. Bost, et al. "A Rsal RFLP at the human myelin protein zero (MPZ) locus." Clinical Genetics 46, no. 4 (2008): 327–28. http://dx.doi.org/10.1111/j.1399-0004.1994.tb04172.x.
Pełny tekst źródłaPrada, Valeria, Mario Passalacqua, Maria Bono, et al. "Gain of glycosylation: A new pathomechanism of myelin protein zero mutations." Annals of Neurology 71, no. 3 (2012): 427–31. http://dx.doi.org/10.1002/ana.22695.
Pełny tekst źródłaLiu, Zhigang, Yong Wang, Ravikiran S. Yedidi, et al. "Crystal structure of the extracellular domain of human myelin protein zero." Proteins: Structure, Function, and Bioinformatics 80, no. 1 (2011): 307–13. http://dx.doi.org/10.1002/prot.23164.
Pełny tekst źródłaYoshida, M., and D. R. Colman. "Parallel Evolution and Coexpression of the Proteolipid Proteins and Protein Zero in Vertebrate Myelin." Neuron 16, no. 6 (1996): 1115–26. http://dx.doi.org/10.1016/s0896-6273(00)80138-5.
Pełny tekst źródłaBielecki, Bartosz, Claudia Mattern, Abdel M. Ghoumari, et al. "Unexpected central role of the androgen receptor in the spontaneous regeneration of myelin." Proceedings of the National Academy of Sciences 113, no. 51 (2016): 14829–34. http://dx.doi.org/10.1073/pnas.1614826113.
Pełny tekst źródłaStögbauer, Florian, Peter Young, Heiko Wiebusch, et al. "Absence of mutations in peripheral myelin protein-22, myelin protein zero, and connexin 32 in autosomal recessive Dejerine-Sottas syndrome." Neuroscience Letters 240, no. 1 (1998): 1–4. http://dx.doi.org/10.1016/s0304-3940(97)00887-2.
Pełny tekst źródłaCatapano, M., T. Ewart, and S. Baker. "Auto-antibodies against gangliosides in patients with Charcot-Marie-Tooth disease." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 42, S1 (2015): S34. http://dx.doi.org/10.1017/cjn.2015.158.
Pełny tekst źródłaGaboreanu, Ana-Maria, Ronald Hrstka, Wenbo Xu та ін. "Myelin protein zero/P0 phosphorylation and function require an adaptor protein linking it to RACK1 and PKCα". Journal of Cell Biology 177, № 4 (2007): 707–16. http://dx.doi.org/10.1083/jcb.200608060.
Pełny tekst źródłaFabrizi, G. M., F. Taioli, T. Cavallaro, et al. "Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero." Acta Neuropathologica 100, no. 3 (2000): 299–304. http://dx.doi.org/10.1007/s004019900175.
Pełny tekst źródłaShames, Igor, Andrew Fraser, Joshua Colby, Wayel Orfali, and G. Jackson Snipes. "Phenotypic Differences between Peripheral Myelin Protein-22 (PMP22) and Myelin Protein Zero (P0) Mutations Associated with Charcot-Marie-Tooth-Related Diseases." Journal of Neuropathology & Experimental Neurology 62, no. 7 (2003): 751–64. http://dx.doi.org/10.1093/jnen/62.7.751.
Pełny tekst źródłaSaiki, Tomokazu, Nobuhisa Nakamura, Megumi Miyabe, et al. "The Effects of Insulin on Immortalized Rat Schwann Cells, IFRS1." International Journal of Molecular Sciences 22, no. 11 (2021): 5505. http://dx.doi.org/10.3390/ijms22115505.
Pełny tekst źródłaSu, Y., D. G. Brooks, L. Li, et al. "Myelin protein zero gene mutated in Charcot-Marie-tooth type 1B patients." Proceedings of the National Academy of Sciences 90, no. 22 (1993): 10856–60. http://dx.doi.org/10.1073/pnas.90.22.10856.
Pełny tekst źródłaBrown, Adrienne M., and Greg Lemke. "Multiple Regulatory Elements Control Transcription of the Peripheral Myelin Protein Zero Gene." Journal of Biological Chemistry 272, no. 46 (1997): 28939–47. http://dx.doi.org/10.1074/jbc.272.46.28939.
Pełny tekst źródłaSalerno, G., C. Ortez, H. Gálvez, et al. "G.P.88 Peripheral neuropathies caused by mutations in the myelin protein zero." Neuromuscular Disorders 22, no. 9-10 (2012): 868. http://dx.doi.org/10.1016/j.nmd.2012.06.218.
Pełny tekst źródłaWrabetz, L. "Different Intracellular Pathomechanisms Produce Diverse Myelin Protein Zero Neuropathies in Transgenic Mice." Journal of Neuroscience 26, no. 8 (2006): 2358–68. http://dx.doi.org/10.1523/jneurosci.3819-05.2006.
Pełny tekst źródłaMaeda, Meiko Hashimoto, Jun Mitsui, Bing-Wen Soong, et al. "Increased gene dosage of myelin protein zero causes Charcot-Marie-Tooth disease." Annals of Neurology 71, no. 1 (2012): 84–92. http://dx.doi.org/10.1002/ana.22658.
Pełny tekst źródłaBriani, Chiara, Fausto Adami, Tiziana Cavallaro, Federica Taioli, Sergio Ferrari, and Gianmaria Fabrizi. "Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy." Muscle & Nerve 38, no. 1 (2008): 921–23. http://dx.doi.org/10.1002/mus.21062.
Pełny tekst źródłaBond, Jeremy P., Raul A. Saavedra, and Daniel A. Kirschner. "Expression and Purification of the Extracellular Domain of Human Myelin Protein Zero." Protein Expression and Purification 23, no. 3 (2001): 398–410. http://dx.doi.org/10.1006/prep.2001.1525.
Pełny tekst źródłaPham, Bach-Nga, Milan Rudic, Didier Bouccara, et al. "Antibodies to myelin protein zero (P0) protein as markers of auto-immune inner ear diseases." Autoimmunity 40, no. 3 (2007): 202–7. http://dx.doi.org/10.1080/08916930701248555.
Pełny tekst źródłaYu, Tianshu, Ling Liang, Xuyang Zhao, and Yuxin Yin. "Structural and biochemical studies of the extracellular domain of Myelin protein zero-like protein 1." Biochemical and Biophysical Research Communications 506, no. 4 (2018): 883–90. http://dx.doi.org/10.1016/j.bbrc.2018.10.161.
Pełny tekst źródła